Founded by Dr. Elizabeth Ruzzo, adyn is helping people find birth control without side effects based on a person's genetic risk and hormone profile. Despite the 47M birth control users in the US, virtually no studies examine the biological factors that explain why individuals respond differently to a given contraceptive method.
Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects.
Our vision is to be earth’s most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.
Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects.
Our vision is to be earth’s most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.
Location: United States, Washington, Seattle
Employees: 1-10
Total raised: $2.5M
Founded date: 2020
Founders name: Elizabeth Ruzzo, PhD
Investors 2
| Date | Name | Website |
| - | Y Combinat... | ycombinato... |
| 02.11.2020 | Pioneer Fu... | pioneerfun... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.04.2021 | Seed | $2.5M | Lux Capita... |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Elizabeth | Ruzzo, PhD | Founder | linkedin.c... | - | e*******h@... |
Mentions in press and media 4
| Date | Title | Description |
| 19.04.2021 | Precision Medicine Company adyn Raises $2.5M Seed Funding for Personalized Birth Control | adyn, a precision medicine company, announced today that it has closed a $2.5 million seed round of funding. The round was co-led by Lux Capital and M13 with participation from Civilization Ventures, Concrete Rose Capital, Y Combinator, Mad... |
| 19.04.2021 | Precision medicine startup adyn raises $2.5 million in seed funding to develop safer birth control options | Side effects are the #1 reason women switch birth control methods, with 52% of women trying four or more methods (and this does not even consider multiple kinds of the pill) before finding one that works for her body. While some side effect... |
| 19.04.2021 | Seattle startup adyn raises $2.5M from 23andMe CEO and others for birth control prescription test | adyn CEO Elizabeth Ruzzo. (adyn Photos) Seattle startup adyn raised a $2.5 million seed round co-led by Lux Capital and M13. The company plans to launch its flagship birth control optimization test later this year and currently has a waitli... |
| 19.04.2021 | adyn Raises $2.5M in Seed Funding | adyn, a Seattle, WA-based precision medicine company, closed a $2.5m seed round of funding. The round was co-led by Lux Capital and M13 with participation from Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund... |